U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Thymic Neuroendocrine Tumor G2

MedGen UID:
354249
Concept ID:
C1710396
Neoplastic Process
Synonyms: Thymic Atypical Carcinoid Tumor; Thymic Neuroendocrine Tumor Grade 2

Definition

A primary thymic neuroendocrine tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism. This type of neuroendocrine tumor has a more aggressive clinical course, compared to grade 1 neuroendocrine tumors. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVThymic Neuroendocrine Tumor G2

Recent clinical studies

Etiology

Tsoli M, Daskalakis K, Wedin M, Angelousi A, Povlsen S, Srirajaskanthan R, Giovos G, Weickert MO, Kogut A, Kos-Kudla B, Oleinikov K, Grozinsky-Glasberg S, Kaltsas G
J Neuroendocrinol 2023 Apr;35(4):e13269. doi: 10.1111/jne.13269. PMID: 37102337
Malczewska A, Witkowska M, Wójcik-Giertuga M, Kuśnierz K, Bocian A, Walter A, Rydel M, Robek A, Pierzchała S, Malczewska M, Leś-Zielińska I, Czyżewski D, Ziora D, Pilch-Kowalczyk J, Zajęcki W, Kos-Kudła B
Neuroendocrinology 2021;111(4):304-319. Epub 2020 Apr 24 doi: 10.1159/000508106. PMID: 32335553

Diagnosis

Tsoli M, Daskalakis K, Wedin M, Angelousi A, Povlsen S, Srirajaskanthan R, Giovos G, Weickert MO, Kogut A, Kos-Kudla B, Oleinikov K, Grozinsky-Glasberg S, Kaltsas G
J Neuroendocrinol 2023 Apr;35(4):e13269. doi: 10.1111/jne.13269. PMID: 37102337
Malczewska A, Witkowska M, Wójcik-Giertuga M, Kuśnierz K, Bocian A, Walter A, Rydel M, Robek A, Pierzchała S, Malczewska M, Leś-Zielińska I, Czyżewski D, Ziora D, Pilch-Kowalczyk J, Zajęcki W, Kos-Kudła B
Neuroendocrinology 2021;111(4):304-319. Epub 2020 Apr 24 doi: 10.1159/000508106. PMID: 32335553
Yoshikawa T, Noguchi Y, Matsukawa H, Kondo J, Matsumoto A, Nakatani Y, Kitamura H, Ito T
Surg Today 1994;24(6):544-7. doi: 10.1007/BF01884576. PMID: 7919739
Hayward IP, Parsons PG
Cancer Res 1984 Jan;44(1):55-8. PMID: 6690060

Therapy

Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A
Rev Endocr Metab Disord 2017 Dec;18(4):485-497. doi: 10.1007/s11154-017-9432-1. PMID: 28890993

Prognosis

Tsoli M, Daskalakis K, Wedin M, Angelousi A, Povlsen S, Srirajaskanthan R, Giovos G, Weickert MO, Kogut A, Kos-Kudla B, Oleinikov K, Grozinsky-Glasberg S, Kaltsas G
J Neuroendocrinol 2023 Apr;35(4):e13269. doi: 10.1111/jne.13269. PMID: 37102337
Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A
Rev Endocr Metab Disord 2017 Dec;18(4):485-497. doi: 10.1007/s11154-017-9432-1. PMID: 28890993

Clinical prediction guides

Malczewska A, Witkowska M, Wójcik-Giertuga M, Kuśnierz K, Bocian A, Walter A, Rydel M, Robek A, Pierzchała S, Malczewska M, Leś-Zielińska I, Czyżewski D, Ziora D, Pilch-Kowalczyk J, Zajęcki W, Kos-Kudła B
Neuroendocrinology 2021;111(4):304-319. Epub 2020 Apr 24 doi: 10.1159/000508106. PMID: 32335553

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...